Manufacture of GMP-grade Cytotoxic T Lymphocytes specific for LMP1 and LMP2 for Patients with EBV-associated Lymphoma

Ítems similars

• Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein–Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant
  per: Sili, Uluhan, et al.
  Publicat: (2012)
• Cytotoxic T Lymphocytes Simultaneously Targeting Multiple Tumor-associated Antigens to Treat EBV Negative Lymphoma
  per: Gerdemann, Ulrike, et al.
  Publicat: (2011)
• EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation
  per: McLaughlin, Lauren P., et al.
  Publicat: (2018)
• Increasing the purity, potency and specificity of ebv-specific T cells to improve the treatment of EBV-positive lymphoma
  per: Sharma, Sandhya, et al.
  Publicat: (2015)
• Antigen-Specific Cytotoxic T Lymphocytes can Target Chemoresistant Side-Population Tumor Cells in Hodgkin’s Lymphoma
  per: Shafer, Jessica A, et al.
  Publicat: (2010)